{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:20:15Z","timestamp":1791994815328,"version":"4.4.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004863","name":"Zhejiang Chinese Medical University","doi-asserted-by":"publisher","award":["2024FSYYZZ13"],"award-info":[{"award-number":["2024FSYYZZ13"]}],"id":[{"id":"10.13039\/501100004863","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004863","name":"Zhejiang Chinese Medical University","doi-asserted-by":"publisher","award":["2024FSYYZY35"],"award-info":[{"award-number":["2024FSYYZY35"]}],"id":[{"id":"10.13039\/501100004863","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011498","name":"Shaoxing Science Technology Bureau","doi-asserted-by":"publisher","award":["2023A14004"],"award-info":[{"award-number":["2023A14004"]}],"id":[{"id":"10.13039\/501100011498","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.intimp.2026.116546","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T02:57:29Z","timestamp":1775789849000},"page":"116546","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Celastrol inhibits the immune escape and proliferation of triple \u2013 negative breast cancer (TNBC) through the LKB1 \u2013 AMPK \u2013 PD-L1\/MYC signaling pathway"],"prefix":"10.1016","volume":"179","author":[{"given":"Mengna","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanyu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2026.116546_bb0005","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-negative breast cancer molecular subtyping and treatment progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast Cancer Res."},{"issue":"7980","key":"10.1016\/j.intimp.2026.116546_bb0010","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/s41586-023-06498-3","article-title":"Spatial predictors of immunotherapy response in triple-negative breast cancer","volume":"621","author":"Wang","year":"2023","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.intimp.2026.116546_bb0015","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s43018-020-00148-7","article-title":"Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer","volume":"2","author":"Mehta","year":"2021","journal-title":"Nat. Cancer"},{"issue":"8","key":"10.1016\/j.intimp.2026.116546_bb0020","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.annonc.2021.05.355","article-title":"First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis","volume":"32","author":"Emens","year":"2021","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.intimp.2026.116546_bb0025","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.annonc.2022.02.004","article-title":"Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized study","volume":"33","author":"Gianni","year":"2022","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.intimp.2026.116546_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2022.102468","article-title":"Multiple Bayesian network meta-analyses to establish therapeutic algorithms for metastatic triple negative breast cancer","volume":"111","author":"Schettini","year":"2022","journal-title":"Cancer Treat. Rev."},{"issue":"488","key":"10.1016\/j.intimp.2026.116546_bb0035","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav0936","article-title":"Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant state","volume":"11","author":"Echeverria","year":"2019","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.116546_bb0040","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12943-017-0621-z","article-title":"Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6\/STAT3, notch and EGFR signaling pathways","volume":"16","author":"Ibrahim","year":"2017","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2026.116546_bb0045","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41392-022-01231-4","article-title":"Celastrol suppresses colorectal cancer via covalent targeting peroxiredoxin 1","volume":"8","author":"Xu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"22","key":"10.1016\/j.intimp.2026.116546_bb0050","doi-asserted-by":"crossref","first-page":"10290","DOI":"10.7150\/thno.46728","article-title":"Celastrol induces ROS-mediated apoptosis via directly targeting peroxiredoxin-2 in gastric cancer cells","volume":"10","author":"Chen","year":"2020","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.intimp.2026.116546_bb0055","first-page":"22","article-title":"Celastrol mitigates inflammation in sepsis by inhibiting the PKM2-dependent Warburg effect","volume":"9","author":"Luo","year":"2022","journal-title":"Mil. Med. Res."},{"issue":"1","key":"10.1016\/j.intimp.2026.116546_bb0060","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.molcel.2017.11.025","article-title":"The PLAG1-GDH1 Axis promotes Anoikis resistance and tumor metastasis through CamKK2-AMPK signaling in LKB1-deficient lung Cancer","volume":"69","author":"Jin","year":"2018","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.intimp.2026.116546_bb0065","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrm.2017.95","article-title":"AMPK: guardian of metabolism and mitochondrial homeostasis","volume":"19","author":"Herzig","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.intimp.2026.116546_bb0070","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41551-019-0375-6","article-title":"Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours","volume":"3","author":"Yao","year":"2019","journal-title":"Nat. Biomed. Eng."},{"issue":"4","key":"10.1016\/j.intimp.2026.116546_bb0075","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1158\/2326-6066.CIR-13-0127","article-title":"PD-L1 expression in triple-negative breast cancer","volume":"2","author":"Mittendorf","year":"2014","journal-title":"Cancer Immunol. Res."},{"issue":"8","key":"10.1016\/j.intimp.2026.116546_bb0080","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.celrep.2017.07.075","article-title":"PDL1 signals through conserved sequence motifs to overcome interferon-mediated cytotoxicity","volume":"20","author":"Gato-Ca\u00f1as","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.intimp.2026.116546_bb0085","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.canlet.2020.02.024","article-title":"PDL1-targeted vaccine exhibits potent antitumor activity by simultaneously blocking PD1\/PDL1 pathway and activating PDL1-specific immune responses","volume":"476","author":"Tian","year":"2020","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.intimp.2026.116546_bb0090","doi-asserted-by":"crossref","first-page":"636","DOI":"10.4143\/crt.2022.343","article-title":"Neoadjuvant Nivolumab plus gemcitabine\/cisplatin chemotherapy in muscle-invasive urothelial carcinoma of the bladder","volume":"55","author":"Kim","year":"2023","journal-title":"Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.intimp.2026.116546_bb0095","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","article-title":"MYC on the path to cancer","volume":"149","author":"Dang","year":"2012","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.intimp.2026.116546_bb0100","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41571-021-00549-2","article-title":"The MYC oncogene \u2013 the grand orchestrator of cancer growth and immune evasion","volume":"19","author":"Dhanasekaran","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.intimp.2026.116546_bb0105","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1158\/2159-8290.CD-15-0507","article-title":"MYC, metabolism, and Cancer","volume":"5","author":"Stine","year":"2015","journal-title":"Cancer Discov."},{"key":"10.1016\/j.intimp.2026.116546_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100963","article-title":"Targeting Myc-driven stress addiction in colorectal cancer","volume":"69","author":"Saeed","year":"2023","journal-title":"Drug Resist. Updat."},{"issue":"11","key":"10.1016\/j.intimp.2026.116546_bb0115","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.trecan.2021.08.002","article-title":"Tilting MYC toward cancer cell death","volume":"7","author":"Harrington","year":"2021","journal-title":"Trends Cancer"},{"issue":"12","key":"10.1016\/j.intimp.2026.116546_bb0120","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1021\/acs.molpharmaceut.9b00717","article-title":"Transferrin-functionalized microemulsions Coloaded with Coix seed oil and Tripterine deeply penetrate to improve cervical Cancer therapy","volume":"16","author":"Guo","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.intimp.2026.116546_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154608","article-title":"Phytochemicals and mitochondria: therapeutic allies against gastric cancer","volume":"110","author":"Zhao","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.intimp.2026.116546_bb0130","doi-asserted-by":"crossref","first-page":"7275","DOI":"10.2147\/IJN.S182475","article-title":"A Tf-modified tripterine-loaded coix seed oil microemulsion enhances anti-cervical cancer treatment","volume":"13","author":"Chen","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.intimp.2026.116546_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102134","article-title":"The Nrf2-NLRP3-caspase-1 axis mediates the neuroprotective effects of Celastrol in Parkinson\u2019s disease","volume":"47","author":"Zhang","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.intimp.2026.116546_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114882","article-title":"Celastrol as an emerging anticancer agent: current status, challenges and therapeutic strategies","volume":"163","author":"Wang","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"10","key":"10.1016\/j.intimp.2026.116546_bb0145","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1007\/s10495-011-0629-6","article-title":"Celastrol inhibits tumor cell proliferation and promotes apoptosis through the activation of c-Jun N-terminal kinase and suppression of PI3 K\/Akt signaling pathways","volume":"16","author":"Kannaiyan","year":"2011","journal-title":"Apoptosis"},{"key":"10.1016\/j.intimp.2026.116546_bb0150","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jad.2022.08.026","article-title":"Celastrol attenuates 6-hydroxydopamine-induced neurotoxicity by regulating the miR-146a\/PI3K\/Akt\/mTOR signaling pathways in differentiated rat pheochromocytoma cells","volume":"316","author":"Guo","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.intimp.2026.116546_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109241","article-title":"Celastrol inhibits rheumatoid arthritis by inducing autophagy via inhibition of the PI3K\/AKT\/mTOR signaling pathway","volume":"112","author":"Yang","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116546_bb0160","doi-asserted-by":"crossref","first-page":"2238137","DOI":"10.1080\/14756366.2023.2238137","article-title":"Synthesis and anticancer properties of celastrol derivatives involved in the inhibition of VEGF","volume":"38","author":"Song","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"6","key":"10.1016\/j.intimp.2026.116546_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109864","article-title":"The role of yes activated protein (YAP) in melanoma metastasis","volume":"27","author":"Leask","year":"2024","journal-title":"iScience"},{"issue":"1","key":"10.1016\/j.intimp.2026.116546_bb0170","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1080\/15548627.2023.2249392","article-title":"Pristimerin suppresses AIM2 inflammasome by modulating AIM2-PYCARD\/ASC stability via selective autophagy to alleviate tendinopathy","volume":"20","author":"Jiang","year":"2024","journal-title":"Autophagy"},{"key":"10.1016\/j.intimp.2026.116546_bb0175","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ebiom.2018.09.031","article-title":"Celastrol ameliorates cisplatin nephrotoxicity by inhibiting NF-\u03baB and improving mitochondrial function","volume":"36","author":"Yu","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.intimp.2026.116546_bb0180","first-page":"4339","article-title":"Antitumor activity of tripterine via cell-penetrating peptide-coated nanostructured lipid carriers in a prostate cancer model","volume":"8","author":"Yuan","year":"2013","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.intimp.2026.116546_bb0185","article-title":"Celastrol-loaded ginsenoside Rg3 liposomes enhance anti-programmed death ligand 1 immunotherapy by inducing immunogenic cell death in triple-negative breast cancer","volume":"139","author":"Huang","year":"2025","journal-title":"Phytomed. Int. J. Phytother. Phytopharm."},{"issue":"2","key":"10.1016\/j.intimp.2026.116546_bb0190","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.gpb.2022.05.002","article-title":"Beneficial effects of Celastrol on immune balance by modulating gut microbiota in experimental ulcerative colitis mice","volume":"20","author":"Li","year":"2022","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"10.1016\/j.intimp.2026.116546_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105725","article-title":"Mechanism of action of celastrol against rheumatoid arthritis: a network pharmacology analysis","volume":"74","author":"Song","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116546_bb0200","doi-asserted-by":"crossref","first-page":"25","DOI":"10.5483\/BMBRep.2017.50.1.114","article-title":"Celastrol suppresses expression of adhesion molecules and chemokines by inhibiting JNK-STAT1\/NF-\u03baB activation in poly(I:C)-stimulated astrocytes","volume":"50","author":"An","year":"2017","journal-title":"BMB Rep."},{"issue":"8","key":"10.1016\/j.intimp.2026.116546_bb0205","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1016\/j.apsb.2024.04.010","article-title":"Endoplasmic reticulum-targeted delivery of celastrol and PD-L1 siRNA for reinforcing immunogenic cell death and potentiating cancer immunotherapy","volume":"14","author":"Wang","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.intimp.2026.116546_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120604","article-title":"Celastrol nanoemulsion induces immunogenicity and downregulates PD-L1 to boost abscopal effect in melanoma therapy","volume":"269","author":"Qiu","year":"2021","journal-title":"Biomaterials"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926003917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926003917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T15:08:26Z","timestamp":1777129706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926003917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":42,"alternative-id":["S1567576926003917"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116546","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Celastrol inhibits the immune escape and proliferation of triple \u2013 negative breast cancer (TNBC) through the LKB1 \u2013 AMPK \u2013 PD-L1\/MYC signaling pathway","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116546","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116546"}}